1. Moore GGI, Harrington JK. Belgian patent 801, 812; US Patent 3, 840, 597 (1974).
2. Swingle KF, Moore GGI. Preclinical pharmacological studies with nimesulide. Drugs Exp Clin Res. 1984;10:587–97.
3. Kulkarni SK. On the safety of nimesulide, a preferential COX-2 inhibitor. Curr Sci. 2002;83:1442–3.
4. Liversidge GG, Cundy KC. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm. 1995;125:91–7.
5. Chaumeil JC. Micronization: a method of improving the bioavailability of poorly soluble drugs. Methods Find Exp Clin Pharmacol. 1998;20:211–5.